Bionano genomics news.

News. Press Releases. Research Reports. ... Bionano Genomics, Inc. (NASDAQ:BNGO) Q3 2023 Earnings Call Transcript November 8, 2023 Bionano Genomics, Inc. misses on earnings expectations. Reported ... Mar 9, 2023 · Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. The word on The Street in general, suggests a Strong Buy analyst consensus rating for BioNano Genomics with a $2.67 average price target, which is a 281.43% upside from current levels.Bionano’s Stratys system for OGM offers increased throughput capabilities to address the needs of mid and high-volume ... Bionano Genomics, Inc. +1 (858) 888-7610 [email protected]. Investor ...

The National Human Genome Research Institute says that strawberries have seven unique chromosomes. However, through human breeding, strawberries are capable of having many different chromosomal combinations by variety.SAN DIEGO and RENO, Nev., Oct. 26, 2022 (GLOBE NEWSWIRE) -- Hamilton and Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that the Long String VANTAGE, a system for automated, high throughput isolation of ultra high molecular weight (UHMW) DNA for use in optical genome mapping (OGM) is commercially …

Sep 21, 2023 · SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that its Chinese OEM partner, Ecobono, a distribution company focused on reproductive health products, has obtained reagent Class I registration from China's NMPA for Bionano's DNA isolation products. Ecobono is Bionano’s third Chinese OEM ...

Nov 27, 2023 · The BioNano Genomics stock price fell by -7.27% on the last day (Monday, 27th Nov 2023) from $1.65 to $1.53. During the last trading day the stock fluctuated 10.07% from a day low at $1.49 to a day high of $1.64. The price has fallen in 5 of the last 10 days but is still up by 17.69% over the past 2 weeks. Volume has increased on the last day ... Oct '23 Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan Oct '23 Bionano Announces Pricing of $80.0 Million Registered Offering and Concurrent Private Placement of Senior Secured Convertible Notes and Warrants Current page 1 2 Aug 4, 2022 · About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software. There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Outlook Therapeutics (OTLK – Research Repor... There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in ...SAN DIEGO, June 12, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the 2023 winners of its Innovator Research Grant program, including grand prize winner Dr. Michael ...

Company profile page for Bionano Genomics Inc including stock price, company news, executives, board members, and contact information.

Bionano Announces Presentation of OGM Utility Across Key Applications at the American Society of Human Genetics (ASHG) Annual Meeting. Oct '23. Bionano Prices $80.0 Million Financing in Convertible Notes and Warrants, Announces Preliminary Q3 2023 Results, and Implements Streamlined Operational Plan. Oct '23.

Bionano Genomics. Market Cap. $61M. Today's Change. (4.64%) $0.07. Current Price. $1.58. Price as of November 29, 2023, 4:00 p.m. ET. You’re reading a free article with opinions that may differ ...SAN DIEGO, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the pricing of (i) $45.0 million aggregate principal amount of senior secured convertible notes due 2025 (the “Registered Notes”) and warrants (the “Registered Warrants”) to purchase 21,660,650 shares of its common stock in a registered offering, a...Latest news about Bionano Genomics, Inc. North American Morning Briefing : Caution -2- 11-14: DJ Transcript : Bionano Genomics, Inc., Q3 2023 Earnings Call, …Bionano Genomics, Inc. (BNGO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term. GlobeNewswire.Aug 4, 2023 · SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ... Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform ...

Aug 30, 2023 · SAN DIEGO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication in Nature Communications demonstrating the utility of optical genome mapping (OGM) as an alternative to karyotyping (KT) and chromosomal microarray (CMA) for the evaluation of CRISPR-Cas9 edited human induced pluripotent stem cell (iPSC) lines in order to uncover possible pathogenic ... SAN DIEGO , May 01, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics , Inc. (BNGO), today announced that on May 1, 2023, it published an open letter to stockholders in support of its proposals at its upcoming annual meeting of stockholders, a copy of which is included at the end of this press release.Bionano Genomics. May 9, 2023 at 4:01 PM · 17 min read. Bionano Genomics. Q1 2023 revenue was $7.4 million, which represents a 30% increase over Q1 2022. Installed base of 259 Saphyr® systems ...Bionano said it expected revenue of $7.3 million to $7.5 million in the first quarter, representing an increase of 28% to 32%, year over year. That would also mean the 10th consecutive quarter of ...SAN DIEGO, April 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the publication of a study from researchers at Radboud University Medical Center showing the use of optical genome mapping (OGM) to identify gene disruptive structural variants (SVs) that might contribute to inherited retinal diseases …

Bionano Genomics SAN DIEGO, Nov. 29, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a publication …11 Jul 2023 ... BNGO stock is receiving lots of attention from retail investors, some who claim Bionano Genomics stock ... BREAKING NEWS - Bionano CFO Reveals Why ...

Bionano Genomics, Inc. (BNGO) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.11 per share a year ago.13 Jun 2023 ... News Release Details. « Back. Bionano Announces Presentation of OGM ... © 2023 Bionano Genomics, Inc. All rights reserved. For Research Use ...SAN DIEGO, Sept. 06, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced a peer-reviewed publication from researchers at the German Cancer Consortium (DKTK) showing the utility of optical genome mapping (OGM) and whole-exome sequencing (WES) in better understanding the mutational landscape of …Jun 14, 2023 · Bionano Announces Results from its Annual Meeting of Stockholders. SAN DIEGO, June 14, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced that its stockholders approved all proposals set forth at its 2023 Annual Meeting, held earlier today. The final voting results will be available in a current report on Form 8-K, which ... The market expects Bionano Genomics, Inc. (BNGO) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2022.Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing ...

BABA. 78.34. +0.96%. 22.22M. Markets. View today's Bionano Genomics Inc stock price and latest BNGO news and analysis. Create real-time notifications to follow any changes in the live stock price.

SAN DIEGO, Sept. 23, 2022 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced the launch of Bionano Laboratories, a new organization that combines Bionano’s optical genome mapping (OGM) data services with the clinical testing services previously offered by Lineagen, and the launch of Bionano Laboratories’ first OGM-based laboratory developed test (LDT).

Bionano's second strategic pillar is to "delight our customers with robust products that are suitable for routine use at scale," he said. In addition to building a strong field support team, Bionano has a number of planned product updates, which include updates to the company's DNA isolation and labeling chemistries as well as integrating OGM ...BNGO Bionano Genomics Inc. 1.65. 0.21 ( 14.58% ) Nov 24 2023 - Closed. Delayed by 15 minutes. 10 Sec. Barclays: High Bar For The Dollar. Quote. Chart.Automate Data Display for Powerful Insights. VIA software amplifies the story of your data by automatically generating powerful visualizations for enhanced variant contextualization across multiple variant types happening in the same genomic region. VIA allows you to drill down to single chromosome, gene, and nucleotide levels for deeper analysis. See Bionano Genomics, Inc. (BNGO) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.News Release Details « Back. Bionano Genomics Reports Second Quarter 2022 Financial Results and Highlights Recent Business Progress. Aug 04, 2022 | PDF …CONTACTS. SAN DIEGO , Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ratio of 1-for-10. The effective time of the reverse stock split will be 5 p.m. ET on August 4, 2023.Aug 4, 2023 · SAN DIEGO, Aug. 04, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO) today announced that the Company effected a reverse stock split of its issued and outstanding common stock, at a ... For the last reported quarter, it was expected that Bionano Genomics, Inc. Would post a loss of $0.90 per share when it actually produced a loss of $1.24, delivering a surprise of -37.78%.

Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine.Title. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ...Jun 13, 2023 · SAN DIEGO, June 13, 2023 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced its participation in the International Society for Stem Cell Research (ISSCR) Annual Meeting 2023 with a broad range of content covering the utility of optical genome mapping (OGM) for research, development, and manufacturing applications in stem ... After surging to an all-time high early in 2021, Bionano Genomics ... By Shrey Dua, InvestorPlace Assistant News Writer Dec 1, 2023 ADVERTISEMENT. Most Popular Today's Market ...Instagram:https://instagram. can you get a mortgage without tax returnsmost expensive quarter valueemerging markets bond etftiffany fong sam bankman fried About Bionano Genomics Bionano Genomics is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company’s mission is to transform the way the world sees the genome through OGM solutions, diagnostic services and software.Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate ... retire on 3 millionbest loans for rv purchase 9 Mei 2023 ... News Release Details. « Back. Bionano Reports First Quarter 2023 ... Bionano Genomics is a provider of genome analysis solutions that can ...Bionano Genomics, Inc. Announces Publication of Interim Readout from Clinical Trial Run by Consortium Analyzing Optical Genome Mapping as Potential Standard of Care for Prenatal Testing Jan 19 Bionano Genomics, Inc. Provides Preliminary Revenue Guidance for the Fourth Quarter and Full Year Ended December 31, 2022 best banks in tennessee Bionano Genomics. April 24, 2023 at 9:54 AM · 8 min read. Bionano Genomics. Preliminary Q1 total revenue expected to be between $7.3 and $7.5 million, which would represent an estimated increase ...Mar 31, 2022 · UPDATE - Bionano Announces Preliminary Q1 2023 Results and Business Updates. Preliminary Q1 total revenue expected to be between $7.3 and $7.5 million, which would represent an estimated increase of 28% to 32% over Q1 2022. Installed base of Saphyr® systems reached 259 as of March 31, 2023, which represents growth of the installed base by 19 ... Apr. 17, 2023 11:19 AM ET Bionano Genomics, Inc. (BNGO) By: Jonathan Block, SA News Editor 9 Comments. Lemon_tm. Bionano Genomics ( NASDAQ: BNGO) is off 19% in Monday morning trading after selling ...